Encube Ethicals Overview
- Year Founded
-
1998
- Status
-
IPO Registration
- Employees
-
1,400
- Latest Deal Type
-
IPO
- (Announced)
- Financing Rounds
-
4
- Investments
-
3
Encube Ethicals General Information
Description
Manufacturer of topical semisolid pharmaceutical products based in Mumbai, India. The company offers topical semisolid formulations and products, including anti-inflammatory agents, antifungals, antiseptics, antibiotics, antivirals, and moisturizers, thereby helping patients get treatment for various topical disorders and diseases.
Contact Information
Website
www.encubeethicals.comCorporate Office
- 803, B Wing, HDIL Kaledonia
- Sahar Road, Andheri (East)
- Mumbai, Maharashtra 400069
- India
Corporate Office
- 803, B Wing, HDIL Kaledonia
- Sahar Road, Andheri (East)
- Mumbai, Maharashtra 400069
- India
Encube Ethicals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Encube Ethicals Comparisons
Industry
Financing
Details
Encube Ethicals Competitors (4)
One of Encube Ethicals’s 4 competitors is Aurigene Pharmaceutical Services, a Corporation company based in Bangalore, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Aurigene Pharmaceutical Services | Corporation | Bangalore, India | ||||
| Akums Drugs and Pharmaceuticals | Formerly PE-Backed | Delhi, India | ||||
| Anthem Biosciences | Formerly PE-Backed | Bengaluru, India | ||||
| Suven Life Sciences | Corporation | Hyderabad, India |
Encube Ethicals Patents
Encube Ethicals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2021061913-A1 | Diclofenac sodium topical solution | Inactive | 27-Sep-2019 | ||
| WO-2020231800-A1 | Topical antifungal formulation | Inactive | 10-May-2019 |
Encube Ethicals Signals
Encube Ethicals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Encube Ethicals Investments & Acquisitions (3)
Encube Ethicals’s most recent deal was a Buyout/LBO with Sanofi India (Soframycin and Sofradex Brands) for . The deal was made on 01-Feb-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Sanofi India (Soframycin and Sofradex Brands) | 01-Feb-2022 | Buyout/LBO | Buildings and Property | ||
| Tioga Research | 01-Dec-2019 | Merger/Acquisition | Drug Discovery | ||
| Intact Therapeutics | 29-Mar-2019 | Seed Round | Drug Discovery |
Encube Ethicals Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Tioga Research | San Diego, CA | 2011 |
Encube Ethicals FAQs
-
When was Encube Ethicals founded?
Encube Ethicals was founded in 1998.
-
Where is Encube Ethicals headquartered?
Encube Ethicals is headquartered in Mumbai, India.
-
What is the size of Encube Ethicals?
Encube Ethicals has 1,400 total employees.
-
What industry is Encube Ethicals in?
Encube Ethicals’s primary industry is Pharmaceuticals.
-
Is Encube Ethicals a private or public company?
Encube Ethicals is a Private company.
-
What is Encube Ethicals’s current revenue?
The current revenue for Encube Ethicals is .
-
How much funding has Encube Ethicals raised over time?
Encube Ethicals has raised $41.2M.
-
Who are Encube Ethicals’s investors?
Gulf Islamic Investments, Quadria Capital, and Plenty Investment Advisors have invested in Encube Ethicals.
-
Who are Encube Ethicals’s competitors?
Aurigene Pharmaceutical Services, Akums Drugs and Pharmaceuticals, Anthem Biosciences, and Suven Life Sciences are competitors of Encube Ethicals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process